Millennium Pharmaceuticals

E852353

Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.

All labels observed (1)

Label Occurrences
Millennium Pharmaceuticals canonical 1

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf biotechnology company ⓘ
cancer drug ⓘ
drug ⓘ
oncology business unit ⓘ
proteasome inhibitor ⓘ
acquiredBy Takeda Pharmaceutical Company ⓘ
activeIngredient bortezomib ⓘ
alternativeName Millennium: The Takeda Oncology Company ⓘ
collaboratesWith academic research institutions ⓘ
other pharmaceutical companies ⓘ
country United States ⓘ
developed Velcade ⓘ
linked to: bortezomib

bortezomib ⓘ
engagesIn clinical trials ⓘ
translational research ⓘ
focusesOn cancer therapeutics ⓘ
hematologic malignancies ⓘ
oncology ⓘ
headquartersLocation Cambridge, Massachusetts ⓘ
indication mantle cell lymphoma ⓘ
multiple myeloma ⓘ
industry biotechnology ⓘ
pharmaceuticals ⓘ
knownFor Velcade ⓘ
linked to: bortezomib

development of bortezomib ⓘ
locatedIn Massachusetts ⓘ
United States ⓘ
mechanismOfAction proteasome inhibition ⓘ
parentCompany Takeda Pharmaceutical Company ⓘ
partOf Takeda Oncology ⓘ
productType hematology drugs ⓘ
oncology drugs ⓘ
regulatoryAgencyApproval U.S. Food and Drug Administration ⓘ
regulatoryApprovalFor Velcade ⓘ
linked to: bortezomib
researchFocus proteasome inhibition ⓘ
small-molecule drugs ⓘ
targeted therapies ⓘ
routeOfAdministration intravenous ⓘ
subcutaneous ⓘ
specializesIn clinical development ⓘ
drug discovery ⓘ
therapeuticArea mantle cell lymphoma ⓘ
mantle cell lymphoma ⓘ
multiple myeloma ⓘ
multiple myeloma ⓘ
tradeName Velcade ⓘ
linked to: bortezomib

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

bortezomib → developer → Millennium Pharmaceuticals ⓘ